About: Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD); and with ELEO, Inc. to develop oral small-molecule inhibitors targeting the PCSK9 pathway for the treatment of hyperlipidemia and cardiovascular diseases. The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.35 (-6.57%)
EVGN NASDAQ Evogene
Evogene share price
Atividade de preço de EVGN
Último preço
$ 0,380
Variação (24h)
0,01 USD (1,48%)
Volume
449
Volume (média 4 sem.)
-
Fechamento anterior
$ 0,37
Último negócio
23 Oct, 12:42 pm GMT+0
Atrasado
23 Oct, 12:42 pm GMT+0
EVGN price performance
Atrasado
23 Oct, 12:42 pm GMT+0
quote.marketSignals